News articles about Luna Innovations (NASDAQ:LUNA) have trended somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Luna Innovations earned a news sentiment score of 0.05 on Accern’s scale. Accern also gave news coverage about the scientific and technical instruments company an impact score of 47.5214659158995 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
These are some of the headlines that may have impacted Accern’s scoring:
LUNA has been the subject of several research analyst reports. Zacks Investment Research downgraded Luna Innovations from a “strong-buy” rating to a “hold” rating in a research note on Friday, May 11th. Northland Securities downgraded Luna Innovations from an “outperform” rating to a “market perform” rating and set a $4.00 target price for the company. in a research note on Friday, August 3rd.
Shares of NASDAQ LUNA traded up $0.05 during midday trading on Friday, hitting $3.95. 111,178 shares of the company’s stock were exchanged, compared to its average volume of 189,391. Luna Innovations has a 12 month low of $1.34 and a 12 month high of $4.32. The company has a market capitalization of $106.56 million, a P/E ratio of 48.75 and a beta of 0.91.
Luna Innovations (NASDAQ:LUNA) last issued its earnings results on Wednesday, August 1st. The scientific and technical instruments company reported $0.03 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.02 by $0.01. The company had revenue of $13.77 million during the quarter, compared to the consensus estimate of $12.90 million. Luna Innovations had a return on equity of 4.98% and a net margin of 34.13%. equities analysts predict that Luna Innovations will post 0.07 EPS for the current fiscal year.
In related news, major shareholder Clinic Carilion sold 8,955 shares of the business’s stock in a transaction on Monday, July 9th. The stock was sold at an average price of $3.40, for a total value of $30,447.00. Following the completion of the sale, the insider now directly owns 2,044,730 shares in the company, valued at approximately $6,952,082. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 165,197 shares of company stock valued at $561,798 over the last 90 days. 10.60% of the stock is currently owned by corporate insiders.
About Luna Innovations
Luna Innovations Incorporated develops, manufactures, and markets fiber optic sensing, and test and measurement products worldwide. It operates in two segments, Products and Licensing, and Technology Development. The Products and Licensing segment offers fiber optic sensing products, as well as test and measurement products to monitor the integrity of fiber optic network components and sub-assemblies, which include optical vector analyzer, optical backscatter reflectometers, and the Phoenix family of tunable lasers; and distributed sensing systems comprising optical distributed sensor interrogator sensing solution with multiple sensors whose inputs are integrated through a fiber optic network and software.
Featured Article: New Google Finance Tool and Screening Stocks
Receive News & Ratings for Luna Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luna Innovations and related companies with MarketBeat.com's FREE daily email newsletter.